What is the ticker symbol for Plus Therapeutics?

Plus Therapeutics trades under the ticker PSTV on NASDAQ.

What sector does Plus Therapeutics operate in?

Plus Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PSTV in a portfolio?

PortView shows PSTV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Plus Therapeutics (PSTV) Stock Analysis

NASDAQHealthcareBiotechnology

$3.87-3.25%

1-year price historyRange $2.92 – $22.24

52-week range$3.87

$2.90$23.43

What Plus Therapeutics does

Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically engineered to address difficult central nervous system (CNS) cancers, such as recurrent glioblastoma, leptomeningeal metastases, and various brain cancers affecting children. The company has also secured a licensing agreement with NanoTx, Corp. to advance and commercialize NanoTx's treatment for glioblastoma. Founded in 1996 and headquartered in Austin, Texas, the firm adopted its current name, Plus Therapeutics, Inc., in July 2019, having previously operated as Cytori Therapeutics, Inc.

Key metrics

Market cap

$9.36M

P/E (TTM)

-2.00

EPS (TTM)

$-1.93

Beta

1.40

Dividend yield

0.00%

Revenue / share

$0.62

50-day avg

$4.30

200-day avg

$7.84

52-week high

$23.43

52-week low

$2.90

CEO

Marc H. Hedrick

ETFs linked to PSTV

Broad-market and Healthcare sector ETFs an investor holding Plus Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PSTV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PSTV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Plus Therapeutics?: Plus Therapeutics trades under the ticker PSTV on NASDAQ.
Which exchange is PSTV listed on?: PSTV is listed on NASDAQ.
What sector does Plus Therapeutics operate in?: Plus Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PSTV in a portfolio?: PortView shows PSTV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.